NASDAQ:CHFS Nuwellis (CHFS) Stock Price, News & Analysis → The ONE AI sSock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free CHFS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.43▼$0.4750-Day Range$3.53▼$6.0252-Week Range$4.86▼$37.50Volume179,931 shsAverage Volume467,323 shsMarket Capitalization$2.64 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Get Nuwellis alerts: Email Address Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About Nuwellis Stock (NASDAQ:CHFS)Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.Read More Ad Banyan Hill PublishingAI Cracks Open Largest Untapped Energy Reserve on EarthThis orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit CHFS Stock News HeadlinesSeptember 11, 2023 | investorplace.comWhy Is Nuwellis (NUWE) Stock Down Today?May 4, 2023 | forbes.comBetterHelp Online Therapy Review 2023March 19, 2024 | Weiss Ratings (Ad)The ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …March 11, 2023 | forbes.comBest Prenatal Vitamins Of 2023, According To ExpertsFebruary 20, 2023 | forbes.comBest Multivitamins For Kids In 2023, According To ExpertsOctober 19, 2022 | globenewswire.comNuwellis Announces Appointment of Chief Financial Officer - GlobeNewswireOctober 18, 2022 | streetinsider.comForm 424B4 Nuwellis, Inc. - StreetInsider.comOctober 17, 2022 | uk.investing.comWhy Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday By Benzinga - Investing.com UKMarch 19, 2024 | Prosper Trading Academy (Ad)Did you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:October 14, 2022 | uk.investing.comWhy Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session By Benzinga - Investing.com UKOctober 14, 2022 | benzinga.comWhy Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday’s Mid-Day Session - Agri - BenzingaOctober 14, 2022 | uk.investing.comWhy IMARA Shares Are Trading Higher By Over 13%; Here Are 22 Stocks Moving Premarket By Benzinga - Investing.com UKOctober 14, 2022 | globenewswire.comNuwellis Announces Pricing of $9.6 Million Upsized Underwritten Public Offering - GlobeNewswireOctober 6, 2022 | marketscreener.comNuwellis : Results of Operations and Financial Condition - Form 8-K - Marketscreener.comOctober 6, 2022 | marketscreener.comNUWELLIS, INC. : Results of Operations and Financial Condition (form 8-K) - Marketscreener.comOctober 5, 2022 | marketscreener.comNUWELLIS, INC. : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) - Marketscreener.comOctober 4, 2022 | msn.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 2.66% - msnNOWOctober 4, 2022 | streetinsider.comNuwellis (NUWE) Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA - StreetInsider.comOctober 3, 2022 | benzinga.comNuwellis shares are trading higher after the company announced results of the AVOID-HF clinical study ana - BenzingaOctober 3, 2022 | in.investing.comU.S. shares higher at close of trade; Dow Jones Industrial Average up 2.66% - Investing.com IndiaOctober 3, 2022 | finance.yahoo.comNuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting - Yahoo FinanceOctober 3, 2022 | globenewswire.comNuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting - GlobeNewswireSeptember 27, 2022 | benzinga.comNuwellis Announces Activation Of New Sites For Its Pivotal REVERSE-HF Trial - Nuwellis (NASDAQ:NUWE) - BenzingaSeptember 27, 2022 | finance.yahoo.comNuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial - Yahoo FinanceSeptember 27, 2022 | globenewswire.comNuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial - GlobeNewswireSeptember 23, 2022 | marketscreener.comNUWELLIS, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.comAugust 31, 2022 | nasdaq.comHealth Care Sector Update for 08/31/2022: NUWE,BNR,SRNE,OSCR - NasdaqSee More Headlines Receive CHFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/01/2021Today3/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical Equipment Sub-IndustryN/A Current SymbolNASDAQ:CHFS Previous SymbolNASDAQ:SSH CUSIPN/A CIK1506492 Webwww.chf-solutions.com Phone(952) 345-4200FaxN/AEmployees66Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($279.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,110,000.00 Net Margins-254.26% Pretax MarginN/A Return on Equity-173.61% Return on Assets-131.01% Debt Debt-to-Equity RatioN/A Current Ratio6.87 Quick Ratio5.97 Sales & Book Value Annual Sales$5.51 million Price / Sales0.48 Cash FlowN/A Price / Cash FlowN/A Book Value$12.79 per share Price / Book0.03Miscellaneous Outstanding Shares6,037,000Free FloatN/AMarket Cap$2.64 million OptionableNot Optionable Beta1.55 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesNestor JaramilloPresident, Chief Executive Officer, CFO & DirectorVitaliy EpshteynSenior Vice President-Operations & EngineeringDavid LernerChief Technology OfficerThomas P. LynchSecretary, Chief Legal & Compliance OfficerLaurent DuhouxVice President-International Business DevelopmentKey CompetitorsTivic Health SystemsNASDAQ:TIVCNuwellisNASDAQ:NUWEHelius Medical TechnologiesNASDAQ:HSDTBioSig TechnologiesNASDAQ:BSGMEloxx PharmaceuticalsNASDAQ:ELOXView All Competitors CHFS Stock Analysis - Frequently Asked Questions How were Nuwellis' earnings last quarter? Nuwellis, Inc. (NASDAQ:CHFS) announced its earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share for the quarter, beating the consensus estimate of ($1.91) by $0.34. The business earned $2.04 million during the quarter. Nuwellis had a negative trailing twelve-month return on equity of 173.61% and a negative net margin of 254.26%. When did Nuwellis' stock split? Nuwellis shares reverse split before market open on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Nuwellis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nuwellis investors own include Biocept (BIOC), Immutep (IMMP), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Zosano Pharma (ZSAN), Avinger (AVGR), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO) and Onconova Therapeutics (ONTX). This page (NASDAQ:CHFS) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThe world’s greatest investmentPorter & CompanySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBitcoin dollar warningStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.